Treatment offers hope for young patients struggling with severe hair loss

Baricitinib Restores Hair Growth in Adolescents With Severe Alopecia Areata

Mar 20, 2025

∙ Paid

A professional medical illustration depicting a scientific breakthrough in alopecia areata treatment for adolescents. The image features a stylized representation of a teenager’s scalp regenerating hair, symbolizing hair regrowth with warm, uplifting colors. A transparent overlay of DNA strands represents the scientific innovation behind the JAK inhibitor baricitinib. Medical research icons, such as test tubes and molecular structures, subtly blend into the background, reinforcing the theme of dermatological advancements. The design is clean, modern, and approachable, avoiding unsettling visuals while ensuring clarity and engagement.

Topline:

A phase 3 clinical trial demonstrated that the JAK inhibitor baricitinib significantly improved hair growth in adolescents with severe alopecia areata, with some achieving a 90% reduction in hair loss over 36 weeks.

Study Details

Alopecia areata (AA) is an autoimmune disorder that leads to unpredictable hair loss, significantly affecting the qual…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.